Portée du marché des dispositifs d'ablation par radiofréquence (2021-2031) et tendances
Radiofrequency Ablation Devices Market Report Scope
| Attribut de rapport | Détails |
|---|---|
| Taille du marché en 2021 | 3,93 milliards de dollars américains |
| Taille du marché d'ici 2031 | 12,08 milliards de dollars américains |
| Taux de croissance annuel composé mondial (2023-2031) | 12,2% |
| Données historiques | 2021-2022 |
| Période de prévision | 2023-2031 |
| Segments couverts | Par produit
|
| Régions et pays couverts | Amérique du Nord
|
| Leaders du marché et profils d'entreprises clés |
|
Radiofrequency Ablation Devices Market Players Density: Understanding Its Impact on Business Dynamics
The Radiofrequency Ablation Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Radiofrequency Ablation Devices Market are:
- Avanos Medical Inc.,
- Stryker,
- Abbott,
- Medtronic,
- Boston Scientific,
- Bard (BD),
Disclaimer
: The companies listed above are not ranked in any particular order.
- Get the Radiofrequency Ablation Devices Market top key players overview
Radiofrequency Ablation Devices Market News and Recent Developments
The radiofrequency ablation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for radiofrequency ablation devices market:
- AtriCure, Inc., a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, announced that it has launched the EnCompass Clamp, a part of the Isolator Synergy Ablation System in the United States. The EnCompass Clamp received FDA 510(k) clearance for ablation of cardiac tissue during cardiac surgery and is designed to make concomitant surgical ablations more efficient. (Source: ATRICURE, INC., Press Release, 2022)
- BD (Becton, Dickinson, and Company), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead to varicose veins. (Source: BD, Press Release, 2021)
Radiofrequency Ablation Devices Market Report Coverage and Deliverables
The “Radiofrequency Ablation Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Analyse du paysage industriel et de la concurrence couvrant la concentration du marché, l'analyse de la carte thermique, les principaux acteurs et les développements récents
- Profils d'entreprise détaillés
Get Free Sample For